NYPATH Would Like Your Input….
What Specific Questions Do You Have About Adolescents, HIV & PrEP?
NYPATH is currently working with Physicians for Reproductive Health, Alwyn Cohall, MD and Allison Eliscu, MD, to develop a two-part webinar focused on HIV including PrEP (Pre-Exposure Prophylaxis). PrEP is a potentially “game changing” intervention for protecting individuals at risk for HIV! Therefore developing provider training on this very important topic is an important priority for NYPATH during our final six months.
What Is PrEP?
PrEP is a daily pill which can be offered to individuals who are HIV negative and at high risk for HIV. In July 2012, the Food and Drug Administration (FDA) approved PrEP for daily use following several clinical trials that established its safety and efficacy. Clinical guidance, issued by the New York State Department of Health in collaboration with John Hopkins University (and updated in October 2015), recommends the use of PrEP as part of a comprehensive prevention plan which includes regular HIV counseling, risk reduction counseling, sexually transmitted disease testing and treatment, and condom use. To access this report click here.
The objectives of the training are to provide an overview of HIV and Adolescents, discuss the research and clinical practices pertaining to integrating PrEP into primary care practice, and teaching medical providers how to identify young people who would be good candidates for PrEP. The training will also include information about initiating and monitoring PrEP treatment onsite and/or by referral.
In order to design this module we would like medical providers to tell us if you have specific questions, thoughts, ideas and/or concerns about Adolescents, HIV & PrEP. Please contact Judy Lipshutz at email@example.com or at 212-304-5237 to provide input and/or ask specific questions about PrEP.